Details
Stereochemistry | ACHIRAL |
Molecular Formula | I2 |
Molecular Weight | 253.8089 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
II
InChI
InChIKey=PNDPGZBMCMUPRI-UHFFFAOYSA-N
InChI=1S/I2/c1-2
Molecular Formula | I2 |
Molecular Weight | 253.8089 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tetraglycine hydroperiodide is an iodine-containing chemical, used for water purification. Tetraglycine hydroperiodide is marketed in tablets; each tablet effectively disinfects 1 liter of clear water or 0.5 liter of tainted water by releasing approximately 8 mg free iodine. It requires approximately 30 minutes to inactivate target microorganisms and make water bacteriologically suitable for drinking. To remove iodine taste, a vitamin C pill is added to the kit.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The susceptibility of the fetus and child to chemical pollutants. Special susceptibility of the host to chemical agents: endocrinologic considerations. | 1974 May |
|
[Necrotizing hepatitis with a fatal outcome after carbimazole therapy]. | 1993 Oct 22 |
|
Subfulminant hepatitis requiring liver transplantation after benzarone administration. | 1994 Jun |
|
Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. | 1995 Jan |
|
Case report: reversible mitral regurgitation and congestive heart failure complicating thyrotoxicosis. | 1996 Mar |
|
Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. | 1997 Jul |
|
Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs. | 1998 Jul |
|
Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. | 2001 Feb |
|
Effects of selenium and iodine on the expression of c-fos and c-jun mRNA and their proteins in cultured rat hippocampus neurons. | 2002 Jun |
|
Effects of selenium and iodine on c-fos and c-jun mRNA and their protein expressions in cultured rat hippocampus cells. | 2002 Winter |
|
Synergistic interaction between excess caffeine and deficient iodine on the promotion of thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine. | 2003 Apr |
|
Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. | 2003 Jan |
|
Effect of selenium supplementation on activity and mRNA expression of type 1 deiodinase in mice with excessive iodine intake. | 2006 Aug |
|
Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation. | 2006 Aug 1 |
|
Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. | 2006 Jul |
|
The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. | 2006 Mar |
|
Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. | 2007 Apr |
|
Goiter and other iodine deficiency disorders: A systematic review of epidemiological studies to deconstruct the complex web. | 2007 Jan |
|
[Effects of iodine excess and selenium supplement on the levels of thyroid hormone and its receptor expression in filial cerebrum of mice]. | 2007 Mar |
|
Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). | 2007 Nov |
|
Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. | 2007 Oct 1 |
|
[Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media]. | 2008 |
|
[The effects of iodine/selenium on the function of antigen presentation of peritoneal macrophages in rats]. | 2008 Jul |
|
Gadolinium and kidney disease: are your patients at risk? | 2008 Mar-Apr |
|
Use of gadolinium for carotid artery angiography and stenting in patients with renal insufficiency. | 2009 Dec |
|
I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. | 2011 Jul |
|
The effects of ammonium perchlorate on thyroid homeostasis and thyroid-specific gene expression in rat. | 2012 Aug |
|
Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice. | 2012 Sep 1 |
|
Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. | 2013 Jan |
|
Developmental iodine deficiency delays the maturation of newborn granule neurons associated with downregulation of p35 in postnatal rat hippocampus. | 2014 Aug |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:49 GMT 2023
by
admin
on
Fri Dec 15 15:32:49 GMT 2023
|
Record UNII |
9679TC07X4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
25448-2
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
50868-9
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
34321-0
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
WHO-VATC |
QD08AG03
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
34320-2
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
76657-6
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
55928-6
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
53872-8
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
25936-6
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
25449-0
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
NCI_THESAURUS |
C896
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
WHO-ATC |
D08AG03
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
WHO-VATC |
QD08AG53
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
EPA PESTICIDE CODE |
46905
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
2494-3
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
44323-4
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
26842-5
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
2492-7
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
DSLD |
184 (Number of products:5290)
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
DEA NO. |
6699
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
||
|
LOINC |
2495-0
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
17606
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
D007455
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
C594
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
34
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
7553-56-2
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
Tincture of iodine
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
231-442-4
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
m6327
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
9679TC07X4
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
Iodine (medical use)
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
807
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
9679TC07X4
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
SUB14239MIG
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
DB05382
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
IODINE
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | Description: Heavy, greyish black plates or granules, having a metallic lustre. Solubility: Very slightly soluble in water; soluble in ethanol (~750 g/l) TS; freely soluble in carbon tetrachloride R, carbon disulfide R, and ether R. Category: External antiseptic. Storage: Iodine should be kept in a tightly closed container, preferably made of glass and provided with a glass stopper. Additional information: Iodine volatilizes slowly at room temperature giving violet, irritant vapours. Definition: Iodine contains not less than 99.5% and not more than 100.5% of I. | ||
|
42355
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
5933
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
4446
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
Iodine
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
100000092589
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
DTXSID7034672
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
24859
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201225
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY | |||
|
Iodine
Created by
admin on Fri Dec 15 15:32:49 GMT 2023 , Edited by admin on Fri Dec 15 15:32:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|